Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II

Condition:   Asthma
Interventions:   Drug: 50 mcg salmeterol HFA MDI;   Drug: placebo;   Drug: 5 mcg tiotropium Respimat®;   Drug: 2.5 mcg tiotropium Respimat®
Sponsors:   Boehringer Ingelheim Pharmaceuticals;   Pfizer
Recruiting – verified September 2010

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days

Dose Proportionality Study: Blood Levels of Fluticasone Furoate (FF) and Vilanterol (VI) Following Different Doses of FF/VI Via an Inhaler

Condition:   Asthma
Interventions:   Drug: Fluticasone furoate 50 mcg (4 inhalations);   Drug: Fluticasone furoate 100 mcg (4 inhalations);   Drug: Fluticasone furoate 200 mcg (4 inhalations);   Drug: Vilanterol 25 mcg (4 inhalations)
Sponsor:   GlaxoSmithKline
Not yet recruiting – verified October 2010

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days

Swimming-Napoleon banned for using incorrect asthma inhaler – Yahoo! Eurosport UK


CBC.ca

Swimming-Napoleon banned for using incorrect asthma inhaler
Yahoo! Eurosport UK
Napoleon, who has taken asthma medication for 20 years, was given an incorrectly labelled inhaler by a pharmacist. The inhaler contained the banned
Australian swimmer Napoleon gets 3-month banUSA Today
Aussie swimmer given three-month banABC Online
FINA Doping Panel Announces Four Separate Decisions TodaySwimmingWorldMagazine.com
Courier Mail
all 46 news articles »

View full post on asthma – Google News